Programs to Help You Access Treatment When You Need It

We offer a number of financial assistance and savings programs to help eligible patients start and stay on treatment. Whether a patient is awaiting insurance approval prior to the start of treatment or looking for financial support to stay on treatment, we’re here to help.

Self-Pay Support Program

Helping eligible cash-paying patients save on medication costs.

Save On Out-Of-Pocket Costs!
Eligible patients pay no more
than $23/Mg

Whether you are prescribed the Saizen® 5 mg or the
Saizen® 8.8 mg vial, eligible patients get a discounted rate at
participating pharmacies with our self-pay program.

Enroll Today!
We Can Help You Get Started

Connections for Growth® provides assistance with highly
trained patient support representatives, insurance
reimbursement and product specialists, and case managers.
We can assist with physician paperwork and prescription
drug benefits.

We’re here for you 24/7, just call 1-800-582-7989
and let us know how we can help.
  • Patient must have a valid prescription for Saizen® (somatropin) for injection
  • Patients pay no more than $23 per milligram of Saizen® (somatropin) for injection
  • Program covers the following products:
    • Saizen® 5 mg vial
    • Saizen® 8.8 mg vial
  • No limit on the number of times the program may be used by a patient
  • Program offer may be used once every 21 days
  • Program is available only for self-pay patients with a valid Saizen® prescription; offer not valid for prescriptions that may be reimbursed under a commercial insurance program
  • The offer is only valid at a pharmacy that has contracted with TrialCard, Inc. to accept the discount and may only be redeemed by TrialCard, Inc.
  • Programs are available only for prescriptions filled in the United States
  • Patients may not combine a program offer with any other rebate, coupon, free trial, or similar offer
  • EMD Serono reserves the right to rescind, revoke, or amend a program at any time without notice
  • Offer not valid for prescriptions that may be reimbursed under a federal or state healthcare program, including Medicare, Medicaid, or any other similar federal or state healthcare program, including any state medical pharmaceutical assistance program
  • Void in any state where prohibited by law, taxed, or otherwise restricted
  • These are not insurance programs

Patients may call 1-800-582-7989 to discover how Connections for Growth® can help them get started.

Patients can get assistance and access to Saizen® (somatropin) for injection while options for insurance coverage are being explored. The Interim Drug Program provides free medication for eligible patients awaiting insurance approval.

Patients may call 1-800-582-7989 to discover how Connections for Growth® can help them get started.

Help for eligible patients who demonstrate financial need.

Eligible patients can receive free medication. Offer is valid for one year from date of enrollment and renewed on an annual basis for income eligible patients until program expiration or when insurance coverage is obtained.
Patient Assistance Program (PAP) Details:

  • Patient must have a valid prescription for Saizen® (somatropin) for injection
  • Patient must be 18 years of age or under
  • Patients will be denied eligibility for the program if they have prescription insurance coverage unless the insurance coverage does not cover Saizen® (somatropin) for injection, in which case the patient will be eligible for the program
  • All determinations about insurance coverage will be made during the CFG reimbursement casework processes
  • Must provide number of people in household for the income eligibility determination. If this value is missing, the application is incomplete.
  • Programs are available only for prescriptions filled in the United States
  • Patients may not combine a program offer with any other rebate, coupon, free trial, or similar offer
  • EMD Serono reserves the right to rescind, revoke, or amend a program at any time without notice
  • Offer not valid for prescriptions that may be reimbursed under a federal or state healthcare program, including Medicare, Medicaid, or any other similar federal or state healthcare program, including any state medical pharmaceutical assistance program
  • Void in any state where prohibited by law, taxed, or otherwise restricted
  • These are not insurance programs

Patients may call 1-800-582-7989 to discover how Connections for Growth® can help them get started.

Eligible patients may save up to $200 off their monthly co-pay or co-insurance for 12 months after program activation, for a total of up to $2,400 for Saizen® (somatropin) for injection.

The easy Savings Co-Pay Program provides assistance to insured patients filling 30-, 60-, or 90-day prescriptions. Significant savings on co-pay or co-insurance: $200 off monthly co-pay or co-insurance for 12 months after program activation, for a total of up to $2,400 for Saizen®.

easy Savings Co-Pay Program Details:

  • Patients must have a valid prescription for Saizen®.
  • Program may save patients up to $200 per month on their co-pay or co-insurance costs. This can mean a savings of up to $2,400 depending on patient’s co-payment.
  • Patients are eligible for a total maximum benefit of $2,400 for the lifetime of the program. If patients have already been enrolled in the program, the benefit they have already received will be deducted from the total maximum benefit.
  • Eligible patients must have a prescription drug benefit that covers Saizen®.
  • Patients may enroll in the program until 12/31/2015.
  • Valid for 1 year from patient enrollment or until program expires.
  • Save up to $200 each time a patient fills a 30-day Saizen® prescription. Patients filling a 60-day or 90-day prescription are eligible for up to $400 and up to $600 off, respectively.
  • Patients may not use program if their private insurance, HMO, or other health or pharmacy benefit program paid for the entire Saizen® prescription.
  • Programs are available only for prescriptions filled in the United States.
  • Patients may not combine a program offer with any other rebate, coupon, free trial, or similar offer.
  • EMD Serono reserves the right to rescind, revoke, or amend a program at any time without notice.
  • Offer not valid for prescriptions that may be reimbursed under a federal or state healthcare program, including Medicare, Medicaid, or any other similar federal or state healthcare program, including any state medical pharmaceutical assistance program.
  • Void in any state where prohibited by law, taxed, or otherwise restricted.
  • These are not insurance programs.

Patients may call 1-800-582-7989 to discover how Connections for Growth® can help them get started.

Indication

What is SAIZEN® (somatropin) for injection?

Saizen is a prescription medicine that is used to treat growth hormone deficiency (GHD) in:

1- Children with growth failure who produce low amounts of growth hormone.
2- Adults with GHD that started as a child or as an adult.

Saizen is an injectable form of a protein called growth hormone that is produced by your body.

Important Risk Information

Who should not take SAIZEN?

Saizen should not be used in children after the growth plates have closed.

Saizen should not be used in children and adults with any of the following medical conditions because serious side effects can occur:

  • A critical illness from surgery, serious injuries, or a severe breathing problem
  • Prader-Willi syndrome who are severely overweight or have a history of breathing
    problems including sleep apnea
  • Cancer or other tumors
  • Allergies to growth hormone
  • Eye problems caused by diabetes

What should patients tell their doctor before taking SAIZEN?

  • If you have or had cancer as a child. There is an increased risk of getting another tumor if you are a childhood cancer survivor
  • If you have diabetes, are at risk for getting diabetes, or have blood sugar levels that are higher than normal. New cases of type 2 diabetes have been reported in patients taking Saizen
  • If you are allergic to growth hormone, or other ingredients such as benzyl alcohol, sucrose, phosphoric acid, sodium hydroxide, or metacresol
  • If you are taking any other medicines (both prescription or over the counter), vitamins, or supplements because these medicines may affect each other. Your doctor may need to adjust the dose of Saizen or other medicines you are taking
  • If you are nursing, pregnant, or plan to become pregnant. It is not known if Saizen passes into your breast milk or could harm your unborn baby

Your doctor will perform certain tests before prescribing SAIZEN and will monitor progress during the course of treatment.

What are the most common side effects of SAIZEN reported in clinical trials in patients treated for GHD?

The most common side effects reported are:

  • An injection site reaction such as pain, numbness, redness, and swelling
  • Muscle and joint pain
  • Tingling and numbness
  • Unusual skin sensations
  • Headache
  • Adults also commonly report swelling associated with fluid retention especially in the legs, arms, and face

Other less common but serious side effects of SAIZEN are:

  • Tumors or cancerous growths
  • High blood sugar (hyperglycemia/diabetes) which can include symptoms of increased thirst and urination, tiredness, trouble concentrating and weight loss
  • Headaches, changes in vision, nausea or vomiting which requires immediate medical attention
  • Serious allergic reactions that require immediate medical attention.
  • Hip and knee pain or a limp in children, which can be a sign that the thigh bone and hip joint may have slipped out of place
  • Curvature of the spine or backbone in children (scoliosis)
  • Pain and tenderness in the abdomen, which could be a sign of a problem with the pancreas

These are not all of the possible side effects. Let your doctor know about any side effects you may experience.

How should you administer SAIZEN?

Patients and caregivers should be trained by a healthcare professional on how to mix and inject Saizen prior to use. Children should always be supervised.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see the Prescribing Information for a complete list of SAIZEN Risk Information.